Trials / Completed
CompletedNCT01718951
Golimumab Versus Pamidronate for the Treatment of Axial Spondyloarthropathy: a 48-week Trial
Golimumab Versus Pamidronate for the Treatment of Axial Spondyloarthropathy: a 48-week Randomized Controlled Trial
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 30 (actual)
- Sponsor
- Tuen Mun Hospital · Other Government
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
To compare the efficacy of golimumab with pamidronate in the treatment of axial spondyloarthropathy
Detailed description
To compare the efficacy of golimumab with pamidronate in the treatment of non-radiological axial spondyloarthropathy
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | golimumab | golimumab |
| DRUG | Pamidronate | pamidronate |
Timeline
- Start date
- 2012-08-01
- Primary completion
- 2014-03-01
- Completion
- 2014-10-01
- First posted
- 2012-11-01
- Last updated
- 2015-05-12
Locations
1 site across 1 country: Hong Kong
Source: ClinicalTrials.gov record NCT01718951. Inclusion in this directory is not an endorsement.